1:25pm ET
Health and Healthcare
Merck and Pfizer Earnings: What to Expect
Merck and Pfizer are set to report their most recent quarterly results before the opening bell tomorrow. Pfizer is one of the most shorted of all Dow stocks.
Companies
/Healthcare
Merck & Co Inc
$147.15
▲ $2.24 (+1.55%) today
Markets closed · 4:58am ET
MRK Coverage
Page 196:50am ET
Investing
Apple, Chevron, Exxon, Pfizer and More Dow Earnings Coming This Week
Six of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week.
9:59am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
6:45am ET
Health and Healthcare
How Biotech and Big Pharma Have Upside Heading Into Earnings
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
9:40am ET
Health and Healthcare
Big Pharma Sees Rising Tide in Short Interest
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
10:30am ET
Health and Healthcare
FDA Accepts for Review the Newest Treatment for C Diff
Merck has just announced that the FDA has accepted a couple new drug applications for review, including for a treatment for Clostridium difficile infections in children.
Chris Lange 10:45am ET
Health and Healthcare
Why Dividend-Paying Large-Cap Pharmaceuticals Could Shine in Q4
These four top large-cap pharmaceutical stocks for investors to consider all pay solid dividends and look like very solid fourth-quarter ideas.
9:20am ET
Health and Healthcare
Short Sellers Grow More Selective in Big Pharma
The September 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
6:20am ET
Investing
4 Conservative Merrill Lynch US 1 Stock Picks That Pay Reliable Dividends
These four outstanding ideas from the US 1 team at Merrill Lynch are decidedly more conservative than most of the list's holdings, but they offer investors excellent total return potential and a…
9:55am ET
Health and Healthcare
Will This Ebola Vaccine Be the Next Big Thing?
NewLink Genetics shares jumped on Wednesday after the firm announced that the FDA has accepted Merck’s Biologics License Application and granted priority review for the investigational Ebola vaccine.
Chris Lange 7:11am ET
Investing
As ESG Investing Expands, the Theme’s Top Stocks Come Into Focus
As, when and if ESG themes continue to gain in popularity, imagine what could happen to some of the top-ranked ESG companies. Imagine also what could happen to some of the companies…
8:35am ET
Health and Healthcare
Short Sellers Can’t Make Up Their Minds on Big Pharma
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
8:35am ET
Health and Healthcare
Big Pharma Sees a Rising Tide in Short Interest
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
9:05am ET
Investing
Friday’s Top Analyst Upgrades and Downgrades: Walmart, Nvidia, Amgen, Applied Materials, Alibaba, Intel, Merck and More
The top analyst upgrades, downgrades and initiations on Friday included Alibaba, Amgen, Applied Materials, Intel, Merck, Nvidia and Walmart.